{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:09:12Z","timestamp":1784030952118,"version":"3.55.0"},"reference-count":23,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1620\/tjem.241.319","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T01:21:54Z","timestamp":1493428914000},"page":"319-326","source":"Crossref","is-referenced-by-count":7,"title":["Alfacalcidol Increases the Therapeutic Efficacy of Ibandronate on Bone Mineral Density in Japanese Women with Primary Osteoporosis"],"prefix":"10.1620","volume":"241","author":[{"given":"Yukio","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Shinshu University School of Medicine"},{"name":"Department of Orthopedic Surgery, Showa-Inan General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Shinshu University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Kamimura","sequence":"additional","affiliation":[{"name":"Center of Osteoporosis and Spinal Disorders, Kamimura Orthopedic Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Ikegami","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Shinshu University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeharu","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Shinshu University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Shinshu University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","unstructured":"Bouillon, R., Okamura, W.H. &amp; Norman, A.W. (1995) Structure-function relationships in the vitamin D endocrine system. <i>Endocr. Rev.<\/i>, 16, 200-257."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Chesnut, C.H. 3rd., Skag, A., Christiansen, C., Recker, R., Stakkestad, J.A., Hoiseth, A., Felsenberg, D., Huss, H., Gilbride, J., Schimmer, R.C. &amp; Delmas, P.D.; Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE) (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. <i>J. Bone Miner. Res.<\/i>, 19, 1241-1249.","DOI":"10.1359\/JBMR.040325"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Christiansen, C. (1993) Skeletal osteoporosis. <i>J. Bone Miner. Res.<\/i>, 8 Suppl 2, S475-480.","DOI":"10.1002\/jbmr.5650081308"},{"key":"4","doi-asserted-by":"crossref","unstructured":"DeLuca, H.F. (2004) Overview of general physiologic features and functions of vitamin D. <i>Am. J. Clin. Nutr.<\/i>, 80 (6 Suppl), 1689S-1696S.","DOI":"10.1093\/ajcn\/80.6.1689S"},{"key":"5","unstructured":"Eisman, J.A., Civitelli, R., Adami, S., Czerwinski, E., Recknor, C., Prince, R., Reginster, J.Y., Zaidi, M., Felsenberg, D., Hughes, C., Mairon, N., Masanauskaite, D., Reid, D.M., Delmas, P.D. &amp; Recker, R.R. (2008) Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. <i>J. Rheumatol.<\/i>, 35, 488-497."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Inderjeeth, C.A., Glendenning, P., Ratnagobal, S., Inderjeeth, D.C. &amp; Ondhia, C. (2014) Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis. <i>Int. J. Women\u2019s Health<\/i>, 7, 7-17.","DOI":"10.2147\/IJWH.S73944"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Iwamoto, J., Takeda, T., Ichimura, S., Matsu, K. &amp; Uzawa, M. (2003) Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis. <i>J. Orthop. Sci.<\/i>, 8, 532-537.","DOI":"10.1007\/s00776-003-0655-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Matsumoto, T., Ito, M., Hayashi, Y., Hirota, T., Tanigawara, Y., Sone, T., Fukunaga, M., Shiraki, M. &amp; Nakamura, T. (2011) A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures-a randomized, active comparator, double-blind study. <i>Bone<\/i>, 49, 605-612.","DOI":"10.1016\/j.bone.2011.07.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Miller, P.D., McClung, M.R., Macovei, L., Stakkestad, J.A., Luckey, M., Bonvoisin, B., Reginster, J.Y., Recker, R.R., Hughes, C., Lewiecki, E.M., Felsenberg, D., Delmas, P.D., Kendler, D.L., Bolognese, M.A., Mairon, N. &amp; Cooper, C. (2005) Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. <i>J. Bone Miner. Res.<\/i>, 20, 1315-1322.","DOI":"10.1359\/JBMR.050313"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Mukaiyama, K., Uchiyama, S., Nakamura, Y., Ikegami, S., Taguchi, A., Kamimura, M. &amp; Kato, H. (2015) Eldecalcitol, in combination with bisphosphonate, is effective for treatment of Japanese osteoporotic patients. <i>Tohoku J. Exp. Med.<\/i>, 237, 339-343.","DOI":"10.1620\/tjem.237.339"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Nakamura, T., Nakano, T., Ito, M., Hagino, H., Hashimoto, J., Tobinai, M. &amp; Mizunuma, H.; MOVER Study Group (2013) Clinical efficacy on fracture risk and safety of 0.5 mg or 1 mg\/month intravenous ibandronate versus 2.5 mg\/day oral risedronate in patients with primary osteoporosis. <i>Calcif. Tissue Int.<\/i>, 93, 137-146.","DOI":"10.1007\/s00223-013-9734-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Nakamura, Y., Ikegami, S., Takanashi, Y., Kamimura, M., Uchiyama, S. &amp; Kato, H. (2016a) Value changes in bone turnover markers and bone mineral density using ibandronate in Japanese postmenopausal osteoporotic patients. <i>J. Nutr. Disorders Ther.<\/i>, 6, 188.","DOI":"10.4172\/2161-0509.1000188"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Nakamura, Y., Kamimura, M., Ikegami, S., Mukaiyama, K., Uchiyama, S., Kato, H. &amp; Taguchi, A. (2015) Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study. <i>BMC Endocr. Disord.<\/i>, 15, 81.","DOI":"10.1186\/s12902-015-0077-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Nakamura, Y., Suzuki, T., Kamimura, M., Ikegami, S., Takanashi, Y., Murakami, K., Uchiyama, S., Taguchi, A. &amp; Kato, H. (2016b) Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic women. <i>Bone Res.<\/i>, doi:10.1038\/boneres.2016.55. [in press].","DOI":"10.1038\/boneres.2016.55"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Orimo, H., Nakamura, T., Fukunaga, M., Ohta, H., Hosoi, T., Uemura, Y., Kuroda, T., Miyakawa, N., Ohashi, Y. &amp; Shiraki, M.; A-TOP (Adequate Treatment of Osteoporosis) research group (2011) Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02. <i>Curr. Med. Res. Opin.<\/i>, 27, 1273-1284.","DOI":"10.1185\/03007995.2011.580341"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Orimo, H., Nakamura, T., Hosoi, T., Iki, M., Uenishi, K., Endo, N., Ohta, H., Shiraki, M., Sugimoto, T., Suzuki, T., Soen, S., Nishizawa, Y., Hagino, H., Fukunaga, M. &amp; Fujiwara, S. (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis: executive summary. <i>Arch. Osteoporos.<\/i>, 7, 3-20.","DOI":"10.1007\/s11657-012-0109-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Paggiosi, M.A., Peel, N., McCloskey, E., Walsh, J.S. &amp; Eastell, R. (2014) Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study. <i>Osteoporos. Int.<\/i>, 25, 2729-2741.","DOI":"10.1007\/s00198-014-2817-z"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ringe, J.D., Farahmand, P. &amp; Schacht, E. (2013) Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on 214 patients. <i>Rheumatol. Int.<\/i>, 3, 637-643.","DOI":"10.1007\/s00296-012-2429-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Ringe, J.D., Farahmand, P., Schacht, E. &amp; Rozehnal, A. (2007) Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin d or Aalfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial). <i>Rheumatol. Int.<\/i>, 27, 425-434.","DOI":"10.1007\/s00296-006-0288-z"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Shiraki, M., Kushida, K., Fukunaga, M., Kishimoto, H., Taga, M., Nakamura, T., Kaneda, K., Minaguchi, H., Inoue, T., Morii, H., Tomita, A., Yamamoto, K., Nagata, Y., Nakashima, M. &amp; Orimo, H. (1999) A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group. <i>Osteoporos. Int.<\/i>, 10, 183-192.","DOI":"10.1007\/s001980050214"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Silverman, S. &amp; Christiansen, C. (2012) Individualizing osteoporosis therapy. <i>Osteoporos. Int.<\/i>, 23, 797-809.","DOI":"10.1007\/s00198-011-1775-y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Ste-Marie, L.G., Brown, J.P., Beary, J.F., Matzkin, E., Darbie, L.M., Burgio, D.E. &amp; Racewicz, A.J. (2009) Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study. <i>Clin. Ther.<\/i>, 31, 272-285.","DOI":"10.1016\/j.clinthera.2009.02.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Wong, S.K., Chin, K.Y., Suhaimi, F.H., Ahmad, F. &amp; Ima-Nirwana, S. (2016) The relationship between metabolic syndrome and osteoporosis: a Review. <i>Nutrients<\/i>, 8, E347.","DOI":"10.3390\/nu8060347"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/241\/4\/241_319\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T12:29:47Z","timestamp":1569155387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/241\/4\/241_319\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.241.319","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}